| 1 |
Sun DD, Wu X, Lin SC, Duan SY. Anti-apoptosis and anti-inflammation activity of circ_0097010 downregulation in lipopolysaccharide-stimulated periodontal ligament cells by miR-769-5p/Krüppel like factor 6 axis. J Dent Sci 2023;18:310-21. [PMID: 36643256 DOI: 10.1016/j.jds.2022.04.024] [Reference Citation Analysis]
|
| 2 |
Shivakumar P, Sunil Shettigar K. Tuberculosis Diagnosis: Updates and Challenges. Mycobacterium - Epidemiology, Prevention, Diagnostic, and Management [Working Title] 2022. [DOI: 10.5772/intechopen.107168] [Reference Citation Analysis]
|
| 3 |
Wang L, Xiong Y, Fu B, Guo D, Zaky MY, Lin X, Wu H. MicroRNAs as immune regulators and biomarkers in tuberculosis. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1027472] [Reference Citation Analysis]
|
| 4 |
Daniel EA, Sathiyamani B, Thiruvengadam K, Vivekanandan S, Vembuli H, Hanna LE. MicroRNAs as diagnostic biomarkers for Tuberculosis: A systematic review and meta- analysis. Front Immunol 2022;13:954396. [DOI: 10.3389/fimmu.2022.954396] [Reference Citation Analysis]
|
| 5 |
Wang Q, Yang D, Zuo Y, Wang D, Li W. Emerging roles of circular RNAs in tuberculosis. Front Immunol 2022;13:995701. [DOI: 10.3389/fimmu.2022.995701] [Reference Citation Analysis]
|
| 6 |
Kameni C, Mezajou CF, Ngongang NN, Ngum JA, Simo USF, Tatang FJ, Nguengo SN, Nouthio APC, Pajiep MAW, Toumeni MH, Madjoumo EST, Tchinda MF, Ngangue RJEM, Koro Koro F, Wade A, Akami M, Ngono ARN, Tamgue O. p50-associated Cyclooxygenase-2 Extragenic RNA (PACER) and Long Non-coding RNA 13 (LNC13) as potential biomarkers for monitoring tuberculosis treatment. Front Trop Dis 2022;3. [DOI: 10.3389/fitd.2022.969347] [Reference Citation Analysis]
|
| 7 |
Chen Y, Hsiao C, Wu C, Chao T, Leung S, Chang Y, Tseng C, Lee C, Hsu P, Wang T, Wang P, Chen T, Lin M. Next generation sequencing reveals miR-431-3p/miR-1303 as immune-regulating microRNAs for active tuberculosis. Journal of Infection 2022. [DOI: 10.1016/j.jinf.2022.08.035] [Reference Citation Analysis]
|
| 8 |
Kelly E, Whelan SO, Harriss E, Murphy S, Pollard AJ, O' Connor D. Systematic review of host genomic biomarkers of invasive bacterial disease: Distinguishing bacterial from non-bacterial causes of acute febrile illness. eBioMedicine 2022;81:104110. [DOI: 10.1016/j.ebiom.2022.104110] [Reference Citation Analysis]
|
| 9 |
Muhammad JS, Khan NA, Maciver SK, Alharbi AM, Alfahemi H, Siddiqui R. Epigenetic-Mediated Antimicrobial Resistance: Host versus Pathogen Epigenetic Alterations. Antibiotics (Basel) 2022;11:809. [PMID: 35740215 DOI: 10.3390/antibiotics11060809] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 10 |
Almatroudi A. Non-Coding RNAs in Tuberculosis Epidemiology: Platforms and Approaches for Investigating the Genome's Dark Matter. Int J Mol Sci 2022;23:4430. [PMID: 35457250 DOI: 10.3390/ijms23084430] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 11 |
Moorthy S, Bhaskar E, S S, Silambanan S. Tuberculosis Diagnostics, a journey from the past Experiences to the Future Directions, Review. AGJSR 2022. [DOI: 10.51758/agjsr-02-2021-0012] [Reference Citation Analysis]
|
| 12 |
Sabirin RM, Yunus J, Agustiningsih D. The effects of aerobic exercise on blood plasma microRNA level in healthy adults: a systematic review and meta-analysis. Sport Sci Health. [DOI: 10.1007/s11332-022-00914-3] [Reference Citation Analysis]
|
| 13 |
Pattnaik B, Patnaik N, Mittal S, Mohan A, Agrawal A, Guleria R, Madan K. Micro RNAs as potential biomarkers in tuberculosis: A systematic review. Non-coding RNA Research 2022;7:16-26. [DOI: 10.1016/j.ncrna.2021.12.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Kim J, Park H, Park SB, Lee EJ, Je MA, Ahn E, Sim B, Lee J, Jin H, Lee KE, Cho SN, Kang YA, Lee H, Kim S, Kim J. Identification of MicroRNAs as Potential Blood-Based Biomarkers for Diagnosis and Therapeutic Monitoring of Active Tuberculosis. Diagnostics (Basel) 2022;12:369. [PMID: 35204460 DOI: 10.3390/diagnostics12020369] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 15 |
Tamgue O, Mezajou CF, Ngongang NN, Kameni C, Ngum JA, Simo USF, Tatang FJ, Akami M, Ngono AN. Non-Coding RNAs in the Etiology and Control of Major and Neglected Human Tropical Diseases. Front Immunol 2021;12:703936. [PMID: 34737736 DOI: 10.3389/fimmu.2021.703936] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 16 |
Matamala N, Lara B, Gómez-mariano G, Martínez S, Vázquez-domínguez I, Otero-sobrino Á, Muñoz-callejas A, Sánchez E, Esquinas C, Bustamante A, Cadenas S, Curi S, Lázaro L, Martínez MT, Rodríguez E, Miravitlles M, Torres-duran M, Herrero I, Michel FJ, Castillo S, Hernández-pérez JM, Blanco I, Casas F, Martínez-delgado B. miR-320c Regulates SERPINA1 Expression and Is Induced in Patients With Pulmonary Disease. Archivos de Bronconeumología (English Edition) 2021;57:457-463. [DOI: 10.1016/j.arbr.2020.03.031] [Reference Citation Analysis]
|
| 17 |
Looney M, Lorenc R, Halushka MK, Karakousis PC. Key Macrophage Responses to Infection With Mycobacterium tuberculosis Are Co-Regulated by microRNAs and DNA Methylation. Front Immunol 2021;12:685237. [PMID: 34140955 DOI: 10.3389/fimmu.2021.685237] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 18 |
Han X, Li T, Fan Y, Wang X, Gu W, Lu W, Yin Y, Meng Q, Zhang W, Zhao J, Zhang F, Fu Y. Screening of 20 Mycobacterium tuberculosis sRNAs in plasma for detection of active pulmonary tuberculosis. Tuberculosis (Edinb) 2021;129:102086. [PMID: 34051642 DOI: 10.1016/j.tube.2021.102086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Wei L, Liu K, Jia Q, Zhang H, Bie Q, Zhang B. The Roles of Host Noncoding RNAs in Mycobacterium tuberculosis Infection. Front Immunol 2021;12:664787. [PMID: 34093557 DOI: 10.3389/fimmu.2021.664787] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 20 |
Wang X, Chi J, Dong B, Xu L, Zhou Y, Huang Y, Sun S, Wei F, Liu Y, Liu C, Che K, Lv W, Chen Y, Wang Y. MiR-223-3p and miR-22-3p inhibit monosodium urate-induced gouty inflammation by targeting NLRP3. Int J Rheum Dis 2021;24:599-607. [PMID: 33650318 DOI: 10.1111/1756-185X.14089] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 21 |
Singh AK, Ghosh M, Kumar V, Aggarwal S, Patil SA. Interplay between miRNAs and Mycobacterium tuberculosis: diagnostic and therapeutic implications. Drug Discov Today 2021;26:1245-55. [PMID: 33497829 DOI: 10.1016/j.drudis.2021.01.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 22 |
Lyu M, Cheng Y, Zhou J, Chong W, Wang Y, Xu W, Ying B. Systematic evaluation, verification and comparison of tuberculosis-related non-coding RNA diagnostic panels. J Cell Mol Med 2021;25:184-202. [PMID: 33314695 DOI: 10.1111/jcmm.15903] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 23 |
MacGregor-Fairlie M, Wilkinson S, Besra GS, Goldberg Oppenheimer P. Tuberculosis diagnostics: overcoming ancient challenges with modern solutions. Emerg Top Life Sci 2020;4:423-36. [PMID: 33258943 DOI: 10.1042/ETLS20200335] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 24 |
Zendehdel Moghadam H, Kheirkhah B, Kazemi Pour N, Kariminik A, دانشگاه آزاد اسلامی, دانشگاه آزاد اسلامی, دانشگاه آزاد اسلامی, دانشگاه آزاد اسلامی. Evaluation of Serum miR-21 Expression Level in Patients Suspected of Mycobacterium tuberculosis. Avicenna J Clin Med 2020;27:184-192. [DOI: 10.52547/ajcm.27.3.184] [Reference Citation Analysis]
|
| 25 |
Mehta P. MicroRNA research: The new dawn of Tuberculosis. Indian J Tuberc 2021;68:321-9. [PMID: 34099196 DOI: 10.1016/j.ijtb.2020.11.011] [Reference Citation Analysis]
|
| 26 |
Sinigaglia A, Peta E, Riccetti S, Venkateswaran S, Manganelli R, Barzon L. Tuberculosis-Associated MicroRNAs: From Pathogenesis to Disease Biomarkers. Cells 2020;9:E2160. [PMID: 32987746 DOI: 10.3390/cells9102160] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 27 |
Goig GA, Torres-Puente M, Mariner-Llicer C, Villamayor LM, Chiner-Oms Á, Gil-Brusola A, Borrás R, Comas Espadas I. Towards next-generation diagnostics for tuberculosis: identification of novel molecular targets by large-scale comparative genomics. Bioinformatics 2020;36:985-9. [PMID: 31580405 DOI: 10.1093/bioinformatics/btz729] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 28 |
Nicolas De Lamballerie C, Pizzorno A, Dubois J, Padey B, Julien T, Traversier A, Carbonneau J, Orcel E, Lina B, Hamelin ME, Roche M, Textoris J, Boivin G, Legras-Lachuer C, Terrier O, Rosa-Calatrava M. Human Respiratory Syncytial Virus-Induced Immune Signature of Infection Revealed by Transcriptome Analysis of Clinical Pediatric Nasopharyngeal Swab Samples. J Infect Dis 2021;223:1052-61. [PMID: 32726438 DOI: 10.1093/infdis/jiaa468] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 29 |
Liu H, Lu G, Wang W, Jiang X, Gu S, Wang J, Yan X, He F, Wang J. A Panel of CircRNAs in the Serum Serves as Biomarkers for Mycobacterium tuberculosis Infection. Front Microbiol 2020;11:1215. [PMID: 32582119 DOI: 10.3389/fmicb.2020.01215] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 30 |
Tribolet L, Kerr E, Cowled C, Bean AGD, Stewart CR, Dearnley M, Farr RJ. MicroRNA Biomarkers for Infectious Diseases: From Basic Research to Biosensing. Front Microbiol 2020;11:1197. [PMID: 32582115 DOI: 10.3389/fmicb.2020.01197] [Cited by in Crossref: 74] [Cited by in F6Publishing: 79] [Article Influence: 24.7] [Reference Citation Analysis]
|
| 31 |
Nicolas De Lamballerie C, Pizzorno A, Dubois J, Padey B, Julien T, Traversier A, Carbonneau J, Orcel E, Lina B, Hamelin M, Roche M, Textoris J, Boivin G, Legras-lachuer C, Terrier O, Rosa-calatrava M. Human Respiratory Syncytial Virus-induced immune signature of infection revealed by transcriptome analysis of clinical pediatric nasopharyngeal swab samples.. [DOI: 10.1101/2020.05.20.106492] [Reference Citation Analysis]
|
| 32 |
Matamala N, Lara B, Gómez-Mariano G, Martínez S, Vázquez-Domínguez I, Otero-Sobrino Á, Muñoz-Callejas A, Sánchez E, Esquinas C, Bustamante A, Cadenas S, Curi S, Lázaro L, Martínez MT, Rodríguez E, Miravitlles M, Torres-Duran M, Herrero I, Michel FJ, Castillo S, Hernández-Pérez JM, Blanco I, Casas F, Martínez-Delgado B. miR-320c Regulates SERPINA1 Expression and Is Induced in Patients With Pulmonary Disease. Arch Bronconeumol (Engl Ed) 2020:S0300-2896(20)30084-3. [PMID: 32439252 DOI: 10.1016/j.arbres.2020.03.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 33 |
Crimi E, Benincasa G, Cirri S, Mutesi R, Faenza M, Napoli C. Clinical epigenetics and multidrug-resistant bacterial infections: host remodelling in critical illness. Epigenetics 2020;15:1021-34. [PMID: 32290755 DOI: 10.1080/15592294.2020.1748918] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 34 |
Pedersen JL, Bokil NJ, Saunders BM. Developing new TB biomarkers, are miRNA the answer? Tuberculosis (Edinb) 2019;118:101860. [PMID: 31472444 DOI: 10.1016/j.tube.2019.101860] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 35 |
Zhang Y, Zhang X, Zhao Z, Zheng Y, Xiao Z, Li F. Integrated bioinformatics analysis and validation revealed potential immune-regulatory miR-892b, miR-199b-5p and miR-582-5p as diagnostic biomarkers in active tuberculosis. Microb Pathog 2019;134:103563. [PMID: 31175974 DOI: 10.1016/j.micpath.2019.103563] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 36 |
Lyu L, Zhang X, Li C, Yang T, Wang J, Pan L, Jia H, Li Z, Sun Q, Yue L, Chen F, Zhang Z. Small RNA Profiles of Serum Exosomes Derived From Individuals With Latent and Active Tuberculosis. Front Microbiol 2019;10:1174. [PMID: 31191492 DOI: 10.3389/fmicb.2019.01174] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 37 |
Nagy G, Németh N, Buzás EI. Mechanisms of vascular comorbidity in autoimmune diseases. Curr Opin Rheumatol 2018;30:197-206. [PMID: 29256898 DOI: 10.1097/BOR.0000000000000483] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 38 |
Meng C, Guo Z, Li D, Li H, Zhou J, Wen D, Luo B. miR-183 and miR-141 in lesion tissues are potential risk factors for poor prognosis in patients with infected abdominal aortic aneurysm. Exp Ther Med 2018;16:4695-9. [PMID: 30542422 DOI: 10.3892/etm.2018.6733] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 39 |
Zhang X, Zhu M, Hu X. Integrated miRNA and mRNA expression profiling to identify mRNA targets of dysregulated miRNAs in pulmonary tuberculosis. Epigenomics 2018;10:1051-69. [PMID: 30052058 DOI: 10.2217/epi-2018-0028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 40 |
Yang T, Ge B. miRNAs in immune responses to Mycobacterium tuberculosis infection. Cancer Lett 2018;431:22-30. [PMID: 29803788 DOI: 10.1016/j.canlet.2018.05.028] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 41 |
Zhou X, Li X, Wu M. miRNAs reshape immunity and inflammatory responses in bacterial infection. Signal Transduct Target Ther 2018;3:14. [PMID: 29844933 DOI: 10.1038/s41392-018-0006-9] [Cited by in Crossref: 79] [Cited by in F6Publishing: 81] [Article Influence: 15.8] [Reference Citation Analysis]
|
| 42 |
Walzl G, McNerney R, du Plessis N, Bates M, McHugh TD, Chegou NN, Zumla A. Tuberculosis: advances and challenges in development of new diagnostics and biomarkers. Lancet Infect Dis 2018;18:e199-210. [PMID: 29580818 DOI: 10.1016/S1473-3099(18)30111-7] [Cited by in Crossref: 164] [Cited by in F6Publishing: 177] [Article Influence: 32.8] [Reference Citation Analysis]
|
